Professor Paul Taylor

Responsibilities

  • Pro-Dean for Student Education

Research interests

A Chemical Genomics approach to Cancer Treatment: Our methods link drugs and natural products to genes that may affect cancer, for example drug candidate VAL401, being developed by ValiSeek Limited. VAL401 is the reformulation of an existing clinical drug to enable use instead in the treatment of cancer (Dilly et al., 2014). Preclinical data indicate potential use of the reformulated drug in lung, pancreatic, breast and prostate cancers.

The Evolutionary Origins of Chemical Messengers in Humans: A collaborative programme with Professor David Scanlan (School of Life Sciences, University of Warwick) and Dr Andrew Millard (Warwick Medical School) building on the finding that retinoic acid is not, as generally thought, an animal ""invention"" but originates in cyanobacteria (Millard et al., 2014). We are currently studying further lateral genetic transfer events using phylogenetic analysis and experimental study of chemical signals in ""model"" cyanobacteria using analytical chemistry and genetics techniques, all leading to new insights into both ecology and medicine.

Chemical Education: A student-engaged research programme (Lambert et al., 2012) around topics such as research-based learning, interdisciplinarity, internationalisation and enterprise education in tertiary education.

Research groups and institutes

  • Chemical Biology and Medicinal Chemistry

Postgraduate research opportunities

We welcome enquiries from motivated and qualified applicants from all around the world who are interested in PhD study. Our research opportunities allow you to search for projects and scholarships.